Effect of hydrocortisone on death, respiratory support among critically ill COVID-19 patients
(JAMA Network) The purpose of this randomized clinical trial in France was to evaluate the effect of low-dose hydrocortisone for the treatment of ICU patients with COVID-19-related acute respiratory failure but the trial was stopped early.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Clinical Trials | COVID-19 | France Health | Hydrocortisone | Infectious Diseases | Respiratory Medicine